Flex Pharma Inc. (FLKS) Soars 5.41% on July 20


Flex Pharma Inc. (FLKS) had a good day on the market for Friday July 20
as
shares jumped 5.41% to close at $0.88. About 681,299 shares traded hands on 799 trades for the day, compared with an average daily volume of
291,607 shares out of a total float of 18.01 million. After opening the trading day at $0.83, shares of Flex Pharma Inc. stayed within a range of $0.92 to
$0.83.

With today’s gains, Flex Pharma Inc. now has a market cap of
$15.76 million. Shares of Flex Pharma Inc. have been trading within a range of $8.98
and $0.80 over the last year, and it had a 50-day SMA of $2.46 and a 200-day SMA of $3.81.

Flex Pharma Inc is a biotechnology company. The company is engaged in developing proprietary treatments for nocturnal leg cramps and spasms associated with severe neuromuscular conditions.

Flex Pharma Inc. is based out of Boston, MA and has some 22 employees. Its CEO is William K. McVicar.

For a complete fundamental analysis of Flex Pharma Inc., check out Equities.com’s Stock Valuation Analysis report for
FLKS
.

Still paying commissions on stock trades? Equities.com now offers 100% commission free stock trading and flat-fee options trading for $89.95/month! Get started today by https://www.equities.com/trading

Flex Pharma Inc. is also a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It’s maintained by Russell
Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell’s indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an
objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It’s a simple approach that gives
a broad, unbiased look at the small-cap market as a whole.


To get more information on Flex Pharma Inc. and to follow the company’s latest updates, you can visit the company’s profile page here:
FLKS’s Profile
. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s
Newsdesk
. Also, don’t forget to sign-up for our daily
email newsletter
to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE:
The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer



Source link

Leave a Reply

Your email address will not be published.